U.S. plans massive coronavirus vaccine testing effort to meet year-end deadline

UK: Oxford vaccine goes to human trials' next phase

The school has been selected as one of the United Kingdom sites for phase III of the University of Oxford's COVID-19 vaccine clinical trial.

Speaking about the recent Reuters survey, Dr. William Schaffner, an infectious disease and vaccine expert at Vanderbilt University Medical Centre in Nashville said: "It's a little lower than I thought it would be with all the attention to COVID-19".

Fox News has reached out to Oxford University and the Medicines and Healthcare products Regulatory Agency with a request for comment.

"The next study will enroll up to 10,260 adults and children and will involve a number of partner institutions across the country", they explained in the statement. Stage 3 of the trials will include studying the vaccine's performance in bodies of a large count of adults, aged 18 years and above.

Building on the group's success in recruiting volunteers to numerous studies mostly focused on respiratory infection predominately pneumonia and vaccines, communications have been sent out to all of the NHS Trusts within Merseyside as well as to CCGs, GPs and care homes asking for volunteers.

To assess whether the vaccine works, Oxford's statisticians will compare the number of infections in the control group to the number of infections in the vaccinated group. How do you address what Mr. Blankfein is saying today and what others have said in the past days, that's it's just time to open this country up and protect the most vulnerable. "How quickly we reach the numbers required will depend on the levels of virus transmission in the community".

The data will then be shared among the +5 companies that will take part.

Earlier this week, drugmaker AstraZeneca said it had secured its first agreements for 400 million doses of the Oxford-developed vaccine, bolstered by a $1 billion investment from a US government agency, for the development, production and delivery of the vaccine, starting in the fall.

The Oxford study is one of the many racing to find an effective and safe vaccine for the coronavirus alongside efforts to contain the spread of the pandemic. It's among a slew of companies, including Pfizer and AstraZeneca, rushing to develop a vaccine for the COVID-19 virus.

Fourteen percent of respondents said they were not at all interested in taking a vaccine, and 10% said they were not very interested.

The firm plans to deliver at least 400 million from September this year, with 100 million provided in Britain.



Latest news

Google says it won't build AI tools for oil and gas drillers
A Google spokesperson said: "Google Cloud is a general objective infrastructure and data processing platform", they said. It said that as profits from oil and gas dwindle, cloud companies were being hired to reduce production costs.

Ala. among few states to incorporate Apple, Google contact tracing technology
Google and Apple have implemented several measures to combat concerns that the apps would lead to a breach of privacy or security. The technology would be able to track those who may have been exposed to COVID-19 through Bluetooth.

Apple Could Postpone iPhone 12 Announcements Until October
It looks like the upcoming iPhone 12 may not come with earphones in a bid to push sales of Apple's wireless AirPods. Apple effectively making its users to buy bluetooth Apple airpods if they don't have already.

Call Of Duty:Warzone Bunkers Can Finally Be Opened After Latest Patch
SMGs and assault rifle both expand the range of engagements in the Gulag, so be careful if you decide to rush your opponent. Hardhat, a Multiplayer map at the scene of construction site, is now available in its own 24/7 playlist.

Respiratory Droplets, Not Surfaces, Are The Main Way COVID-19 Is Spread
The reason why the CDC changed its vocabulary today might leave people confused. "Just don't wipe down food with disinfectant". But the new guidelines, issued this week, said "this is not thought to be the main way the virus spreads".

Other news